Joshua Smith
Pediatric Endocrinology · Idaho Falls, IDNPI 1154528727
Payments from drug & device makers
Across 1,399 payments — averaging $3945.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$3M
- Abbott$1.5M
- Novo Nordisk AS$261K
- Eli Lilly$250K
- AbbVie$180K
- Biomarin Pharmaceutical Inc.$101K
- plus $208K from 42 others
Across 2 payments — averaging $2781.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$6K
What the payments were for
- Consulting fees$4429%
- Food & beverage$4,59491%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xience Alpine coronary stent system$167
- SKYTROFA$125
- Tirosint$111
- Licart$111
- FLECTOR$111
How this compares
Too few pediatric endocrinology providers in Idahoto place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Idaho Falls
- Daniel FlynnBoise$601K
- Cydney FentonBoise$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.